Longeveron Inc. (LGVN) vs Mangoceuticals, Inc. (MGRX)
A side-by-side comparison of Longeveron Inc. and Mangoceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LGVN
Longeveron Inc.
$2.41HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
MGRX
Mangoceuticals, Inc.
$0.41HealthcareDelayed quote: Oct 6, 2026, 10:48 AM EDT
Total return — LGVN vs MGRX
growth of $100 · dividends reinvested · last 4yLGVN -99.1% (-68.9%/yr)MGRX -99.3% (-71.1%/yr)LGVN compounded faster over this window
LGVN MGRX
LGVN vs MGRX: by the numbers
- •LGVN is the larger company ($7M vs $7M market cap).
- •Both run net losses; LGVN's is the smaller (-1977.59% vs -4791.48% net margin).
Metrics side by side
Valuation
| Metric | LGVN | MGRX |
|---|---|---|
| P/S ratio | 6.18 | 22.23 |
| P/B ratio | 0.71 | 0.56 |
Profitability
| Metric | LGVN | MGRX |
|---|---|---|
| Gross margin | 69.76% | 54.43% |
| Operating margin | -1942.20% | -4200.46% |
| Net margin | -1977.59% | -4791.48% |
| ROE | -225.67% | -120.58% |
| ROIC | -211.58% | -102.91% |
Growth (annualized)
| Metric | LGVN | MGRX |
|---|---|---|
| Revenue CAGR (5Y) | -21.21% | N/A |
| Total return CAGR (5Y) | -62.60% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.